Ocean Biomedical Inc.

NASDAQ: OCEA · Real-Time Price · USD
0.01
0.00 (26.58%)
At close: Jun 09, 2025, 3:19 PM

Ocean Biomedical Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-3.2M -3.8M -1.39M -3.27M -5.27M -9.9M -11.17M -9.89M -14.11M -13.99M -21.56M -25.08M -23.52M -62.34M -55.05M -50.17M -44.84M
Interest Income
n/a n/a n/a n/a n/a n/a 1.02M 1.38M 1.52M 1.52M 501.26K 149.49K 9.19K 2.27K n/a n/a n/a
Pretax Income
-24.54M -3.3M -26.62M -35.18M -30.97M -111.37M -94.11M -81.04M -75.34M -13.32M -21.9M -25.77M -23.78M -62.34M -55.05M -50.18M -44.84M
Net Income
-24.54M -3.3M -26.62M -35.18M -30.97M -172.01M -154.74M -141.67M -136.41M -13.75M -22.34M -26.2M -23.78M -62.34M -55.05M -50.18M -44.84M
Selling & General & Admin
4.14M 3.77M 1.38M 2.96M 4.93M 9.19M 10.45M 9.47M 10.52M 7.6M 11.97M 12.83M 11.8M 28.41M 24.26M 22.05M 19.37M
Research & Development
18K 26K 9K 314K 342K 709K 726K 2.28M 5.44M 8.25M 11.44M 12.25M 11.72M 33.93M 30.74M 28.08M 25.41M
Other Expenses
n/a n/a n/a n/a -1K -12.68M -12.68M -12.68M -13.38M -697K -697K -696K 3K 2K 51K 49K 49K
Operating Expenses
4.16M 3.8M 1.39M 3.27M 5.27M 9.9M 11.17M 9.89M 14.11M 13.99M 21.56M 25.08M 23.52M 62.34M 55.05M 50.17M 44.84M
Interest Expense
1.41M 2.05M 2.11M 1.95M 2.1M 3M 1.88M 1.65M 1.41M 135.71K 760K 699K 266K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a 54.6K 54.6K 54.6K 54.6K n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.2M 3.8M 1.39M 3.27M 5.27M 9.9M 11.17M 9.89M 14.11M 13.99M 21.56M 25.08M 23.52M 62.34M 55.05M 50.17M 44.84M
Income Tax Expense
-3.3M -3.3M n/a n/a 668K 61.3M 61.25M 61.22M 60.99M 350.04K 335.81K 360.89K -71.11K -125.33K -55.21K -100.51K -101.51K
Shares Outstanding (Basic)
27.5M 27.5M 27.49M 27.49M 27.34M 27.34M 26.61M 26.47M 24.82M 13.22M 13.22M 10.6M 11.91M 13.2M 13.47M 13.47M 16.84M
Shares Outstanding (Diluted)
27.5M 27.5M 27.49M 27.49M 27.34M 27.34M 26.61M 26.47M 24.82M 13.22M 13.22M 10.6M 11.91M 13.2M 13.47M 13.47M 16.84M
EPS (Basic)
-0.9 -0.12 -0.97 -1.3 -1.16 -6.8 -6.15 -5.7 -5.94 -1.23 -1.88 -2.16 -1.83 -3.99 -3.41 -3.05 -2.65
EPS (Diluted)
-0.9 -0.12 -0.97 -1.3 -1.16 -6.8 -6.15 -5.7 -5.94 -1.23 -1.88 -2.16 -1.83 -3.99 -3.41 -3.05 -2.65
EBITDA
-21.07M -7.43M -24.51M -33.23M -27.28M -112.7M -81.06M -70.87M -67.39M -957.74K -24.43M -25.71M -23.77M -62.34M -55.05M -50.17M -44.84M
EBIT
-13.64M n/a -24.51M -33.23M -27.28M -112.7M -81.06M -70.87M -67.39M -957.74K -24.43M -25.71M -23.77M -62.34M -55.05M -50.17M -44.84M
Depreciation & Amortization
-14.23M n/a -18.82M -29.96M -13.93M -40.83M -23.76M -12.6M -12.6M 81.96K 98.47K 125.39K 182.2K 236.41K 220.15K 213.45K 157.64K